MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Wang, Q; Zhao, DY; Xian, M; Wang, Z; Bi, EG; Su, P; Qian, JF; Ma, XZ; Yang, MJ; Liu, LT; Zu, YL; Pingali, SR; Chen, KF; Cai, Z; Yi, Q

Cai, Z (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China.; Yi, Q (corresponding author), Houston Methodist Res Inst, Canc Ctr, Ctr Translat Res Hematol Malignancies, Houston, TX 77030 USA.

BLOOD, 2020; 136 (22): 2557

Abstract

Multiple myeloma (MM) remains largely incurable despite significant advances in biotherapy and chemotherapy. The development of drug resistance is a m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索